Bertram Gilka-Bötzow

GENEART AG provides integrated system solutions for DNA engineering focusing on gene synthesis, evolution and plasmid services. The company provides the technologies for pharmaceutical and biotechnology companies, chemical industry and universities for the development and production of new bio therapeutics, vaccines and improved industrial enzymes. Its service portfolio is comprised of 4 fields of business, which range from the production of synthetic genes and the generation of gene variants/gene libraries in combinatorial biology right through to the production of plasmid DNA. The company was founded by Ralf Wagner and Marcus Graf in 1999 and is headquartered in Regensburg, Germany.

S-Refit AG, which stands for Sparkassen-Refit AG, is a regional private equity firm located in Regensburg on the eastern side of Bavaria in Germany. S-Refit was established in 1990 as an investment fund at the initiative of OTTI-Ostbayerisches Technologie-Transfer-Institut eV, the not-for-profit East-Bavarian Technology Transfer Institute. A stock corporation since 2002, S-Refit is a leading Bavarian holding company structured as a joint venture and financed by the region's Sparkassen, publicly-supported local savings banks. The firm manages the medTECH Capital fund, backed by Sparkasse Erlangen, and the S-Refit EFRE Bavaria fund, which receives public financing from the European Fund for Regional Development through the Bavarian State Ministry of Economic Affairs, Infrastructure, Transport and Technology.

AKT Informationssysteme AG provides order management systems for the distribution of telecommunications, Internet and related services. The company was founded by Benjamin Mueller in 1993 and is headquartered in Passau, Germany.